Pillar Pacific Capital Management’s iShares Biotechnology ETF IBB Stock Holding History

Pillar Pacific Capital Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-2,970	Closed	-$255K	–	301
2016 Q2	$255K	Hold	2,970	–	–	0.04%	247
2016 Q1	$258K	Buy	+2,970	New	+$266K	0.04%	240

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return

Pillar Pacific Capital Management's IBB Position: Q3 2016 in Review

Pillar Pacific Capital Management sold out of iShares Biotechnology ETF (IBB) in Q3 2016, closing a stake of 2,970 shares — an estimated $255K sold.

Pillar Pacific Capital Management first reported a position in IBB in Q1 2016 and held it in 2 quarters. The position peaked at $258K in Q1 2016. 463 funds tracked by Wall St. Rank hold IBB as of Q3 2016.

Pillar Pacific Capital Management reported no remaining iShares Biotechnology ETF position as of Q3 2016 after selling out during the quarter.
Pillar Pacific Capital Management sold 2,970 iShares Biotechnology ETF shares in Q3 2016, an estimated $255K.
Pillar Pacific Capital Management first reported a position in iShares Biotechnology ETF in Q1 2016 and held it in 2 quarters.
Pillar Pacific Capital Management's iShares Biotechnology ETF position peaked at $258K in Q1 2016.
463 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2016.

Based on Pillar Pacific Capital Management's 13F filing for Q3 2016, filed 4 Nov 2016.